STAT
@statnews
Reporting from the frontiers of health & medicine.
Sign up for any of our newsletters here:
4.7K Following 165.1K Followers
Tomorrow at 1 p.m. ET: Biosimilars: Have We Reached an Inflection Point?
STAT’s Ed Silverman will moderate a virtual conversation with experts about the next wave of biosimilars, shifting FDA policies and what’s next for the market. Join us online.
Show more
Members of Congress push back on plan to create a commission of political appointees to review NIH grants
After news leaked about a plan to create a panel of political appointees to sign off on all NIH grants, several members of Congress voiced strong opposition against increased White House control of federal biomedical research funding.
House Rep. Rosa DeLauro (D-Conn.) called the White House Office of Management and Budget "an out-of-control agency that not only needs additional oversight but should also have its authorities removed or constrained," and called the proposal in question "extraordinarily dangerous." Sen. Patty Murray (D-Wash.) wrote in a statement, "I’m going to fight this corrupt heist every step of the way."
Read more about the contentious NIH grant funding plan here.
Show more
HHS laid out its latest strategies to speed the shift away from using animals in medical testing. Beginning next February, research methods other than animal testing can be used when “appropriate” for determining the safety of drugs and biologics, according to a final FDA rule issued yesterday. At the same time, the NIH unveiled several initiatives designed to encourage the use of non-animal approaches such as cell-based assays, organs-on-a-chip, and computer models.
STAT’s Ed Silverman wrote about the new policies and spoke with advocates on both sides of the long-running debate. Read more.
Show more
Medicines for brittle bones and breakages are grabbing the attention of the pharma industry, which has been incentivized by a long-awaited regulatory change.
In this edition of STAT's AI Prognosis newsletter: Brittany Trang offers a few stories to make sense of the AI doom/slowdown talk, and more.
A STAT Investigation: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors?
A private equity owned hospital chain is converting to a nonprofit. On its face, it sounds like a good deal.
But who actually benefits? Quorum's hospitals will get loaded with 30% more debt while Quorum's lenders are almost made whole.
via @statnews
Show more
As of next month, a loophole that allows Americans to personally import their medications by mail is closing
Biotech investment firm Flagship Pioneering has been awarded a contract by the Department of Defense to advance countermeasure technologies against biological threats.
Flagship Pioneering has been awarded a contract by the Department of Defense to advance countermeasure technologies against biological threats.
The investment firm is receiving $47 million and will administer the funding to its portfolio companies.
Show more
The DOJ settled with NYU Langone and the University of Pittsburgh Medical Center over gender-affirming care to young people.
Both hospitals agreed to stop providing puberty blockers, hormones, and rare surgical procedures to minors. Here's what's next.
Show more
The chilling effect of the Trump administration's dogged offensive against transgender health care has been swift, with dozens of hospitals across the U.S. ending care, even if they haven't been…
Show more
“The maternal mental health needs of women like me have been badly underprioritized in American society,” writes Meg LeDuc.
Some health insurers push back on a Medicare proposal that would disrupt how doctors can bill for remotely monitoring patients' health.
Medicines for osteoporosis are grabbing the attention of the pharma industry, which has been incentivized by a long-awaited regulatory change.
Other private equity-owned hospital chains have collapsed in recent years, so the stakes are high for Quorum.
HHS unveils new initiatives to reduce animal testing in drug development
"When health secretary Robert F. Kennedy Jr. talks about the chronic disease epidemic ravaging America’s young, I am one of the people he is speaking about, Nick Florko writes. "At 34 years old, I am overweight and already suffering from high cholesterol and high blood pressure. I have ADHD so bad I often forget to brush my teeth in the morning."
"I tell you all of this as STAT’s inaugural reporter on trust in science, because I know what it means to be searching for an explanation to what ails you, and a way to fix it. ... We as a society have more scientific knowledge at our fingertips than ever before. But knowledge alone is clearly not enough." Read more.
Show more
Two former FDA commissioners come out in support of the nomination of Heidi Overton to lead that agency.
